Recent Quotes

Second Sight Medical Products Inc develops, manufactures, and markets implantable prosthetic devices to create an artificial form of useful vision for blind individuals. The company's product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include the implant and external components. Geographically, the company operates in the United States, Italy, China, and of which key revenue is derived from the United States.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-12
REV		(EXPECTED)2021-08-12

Q1 2021		Est.		Actual		Surprise
EPS				-0.120
REV				0

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
EYES	Second Sight Medical	6.50	-0.50	-7.14%		181.4M

Second Sight Medical Frequently Asked Questions

How do I buy Second Sight Medical (EYES) stock?

You can purchase shares of Second Sight Medical (NASDAQ: EYES) through any online brokerage.

View our list of the best stock brokerages.

Who are Second Sight Medical's (EYES) competitors?

Other companies in Second Sight Medical’s space includes: Pro-Dex (NASDAQ:PDEX), Venus Concept (NASDAQ:VERO), Apollo Endosurgery (NASDAQ:APEN), Zosano Pharma (NASDAQ:ZSAN) and Apyx Medical (NASDAQ:APYX).

What is the target price for Second Sight Medical (EYES) stock?

The latest price target for Second Sight Medical (NASDAQ: EYES) was reported by Dougherty & Co. on December 13, 2019. The analyst firm set a price target for 2.00 expecting EYES to fall to within 12 months (a possible -69.23% downside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Second Sight Medical (EYES)?

The stock price for Second Sight Medical (NASDAQ: EYES) is $6.5 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Does Second Sight Medical (EYES) pay a dividend?

There are no upcoming dividends for Second Sight Medical.

When is Second Sight Medical (NASDAQ:EYES) reporting earnings?

Second Sight Medical’s Q2 earnings are confirmed for after-market on August 12, 2021.

Is Second Sight Medical (EYES) going to split?

There is no upcoming split for Second Sight Medical.

What sector and industry does Second Sight Medical (EYES) operate in?

Second Sight Medical is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.